Full-mold cast hydrogel and biocompatible color lenses produced in ISO 13485 cleanroom facilities under CE MDR regulatory certification. Ready for international brand registration and private-label scaling.
Unlike trading brokers, Eyebeauty serves as the dedicated international operational headquarters for our family-owned industrial manufacturing facilities, controlling every aspect from monomer chemistry to sterilized blister packaging.
Since the establishment of our primary production line in 1984 under Gansu Constar Technology Group, our industrial facilities have prioritized medical regulatory compliance. Today, our production sites maintain:
Our expansive production base at Hunan Haipuming Technology (Liangguo Group) specializes in high-volume, automated cosmetic and corrective soft contact lens fabrication. Key proprietary capabilities include:
Sourcing contact lenses on an OEM/ODM basis requires navigating complex medical device regulations, rigorous material engineering, and logistical realities. For optical retail chains, ophthalmic distributors, and digital-native cosmetic brands, vendor audits must extend far beyond price-per-pair metrics.
The clinical baseline of any soft contact lens depends on its monomeric composition. Traditional PHEMA (poly-2-hydroxyethyl methacrylate) hydrogels provide predictable hydration (38%-42%) but lower oxygen transmissibility (Dk/t around 12-25). For prolonged wear and premium positioning, evaluate the factory's silicone-hydrogel polymerization capability, achieving Dk/t ratings above 80 to eliminate hypoxic corneal complications.
Comfort upon insertion is governed by the peripheral edge design. High-precision cast molding produces tapered, chisel-shaped or rounded edges that minimize eyelid interaction during blinking. Avoid suppliers utilizing legacy lathe-cutting for soft lenses without multi-stage polishing, as irregular edge radii dramatically increase foreign-body sensation and conjunctival staining.
Sterility Assurance Levels (SAL 10⁻⁶) must be verified through validated terminal moist heat (steam autoclave) cycles conforming to ISO 17665. Sourcing managers must demand complete F0 cycle lethality documentation, bioburden validation prior to capping, and accelerated aging stability reports substantiating 3- to 5-year packaging shelf-life claims.
As consumer habits, environmental standards, and ophthalmic science evolve, B2B procurement strategies are shifting toward agile manufacturing, advanced ocular biopolymers, and stringent regulatory harmonization.
Global consumer preference is rapidly consolidating around 1-Day daily disposable modalities. Eliminating lens cases and chemical disinfecting solutions reduces the incidence of contact lens-induced acute red eye (CLARE) and microbial keratitis. Buyers are reallocating supply agreements from monthly and annual vials into automated high-speed daily blister packaging lines.
To address screen-induced dry eye syndrome among digital device users, lens polymers are being integrated with internal wetting agents such as Hyaluronic Acid (HA), Polyvinylpyrrolidone (PVP), and 2-Methacryloyloxyethyl Phosphorylcholine (MPC). These biomimetic hydrogels resist lipid and protein deposition while maintaining tear film stability over 14+ hours of continuous wear.
Brands increasingly require flexible batch runs rather than rigid 50,000-unit factory minimums. Advanced manufacturing lines allow rapid changeover of blister foil graphics, multi-lingual outer boxes (e.g., FDA, CE, MFDS compliance), and regional diopter distributions (plano cosmetic up to -10.00D corrective powers), enabling brands to test localized market trends with reduced capital exposure.
Global medical device agencies enforce Unique Device Identification (UDI) tracking and complete supply chain transparency. Factories must supply fully validated Technical Documentation Files (TDF), Biocompatibility testing data (ISO 10993 series), Cytotoxicity, Ocular Irritation, and Systemic Toxicity reports for immediate submission to regulatory authorities worldwide.
Soft contact lens manufacturing is branching into specialized clinical niches. Aspheric aberration control designs enhance low-light contrast sensitivity, while dual-focus peripheral defocus soft lenses are gaining prominence in pediatric and youth myopia progression management, opening substantial high-margin segments for OEM brand portfolios.
Environmental accountability is reshaping primary and secondary packaging. Production lines are adopting ultra-compact blister cups that reduce virgin polypropylene plastic usage by up to 30%, coupled with soy-ink recycled carton packaging and saline solutions free from persistent synthetic additives.
Key technical answers to facilitate smooth factory audits, regulatory validation, and private-label brand scaling.
Discuss your product specifications, private label packaging requirements, or regulatory dossier needs directly with our engineering and international business team. No intermediaries — complete factory accountability.
Contact Us